Posts by camerontucker
CGT Global Welcomes Dr. Jerome Ritz to Its Board of Advisors, Enriching Knowledge of Cellular Therapies and Hematology
By:CGT GlobalviaBusiness Wire August 14, 2025 at 09:00 AM EDT CGT Global, a biotechnology leader accelerating access to life-changing cell and gene therapies, today announced the appointment of Jerome Ritz, MD, to its Board of Advisors. Dr. Ritz brings a distinguished career in hematology, oncology, cell manufacturing, and the advancement of cell and gene therapies.…
For More InformationCGT Global Appoints Dr. Andrew Branagan to Board of Advisors, Expanding Cell and Gene Therapy Expertise
CGT Global, a leading biotechnology company driving the development and delivery of innovative cell and gene therapies, today announced the appointment of Andrew Robert Branagan, MD, PhD, to its Board of Advisors. Dr. Branagan brings extensive expertise in hematologic malignancies, immunology, and the development of novel therapeutic strategies, including cellular therapies. This press release features…
For More InformationBehind the Scenes at CGT Global’s Laboratory: Life in the Lab with Bryan
By Joanna Wirkus, PhD CD34+ Cell Isolation Process Previously in our Meet the Scientific Team blog, we gained insight into the background of CGT Global’s Laboratory Operations Manager in Folsom, California — Bryan — and his inspiration for his work. Today, we go behind the scenes, or behind the bench, to see what a day…
For More InformationMeet CGT Global’s Scientific Team: Bryan Pulling – Laboratory Operations Manager
Written by Joanna Wirkus, PhD Every day at CGT Global, our experienced team collaborates to deliver high quality cells to scientists around the world. Success starts with the strength of our team and the dedication of the people who power it. In this edition of Meet the Scientific Team, we’re proud to spotlight Bryan Pulling…
For More InformationFast-Track Your Therapy Pipeline with CGT Global’s Clinical Capabilities
By: Joanna Wirkus Despite exponential progress in the field of biology, inherited and preventable diseases continue to burden billions of people worldwide. Bridging the gap between laboratory discoveries and transformative clinical therapies remains a significant challenge, , and an urgent opportunity. High-quality biospecimens are foundational to this effort, enabling the advancement of cell and gene…
For More InformationAll About B Cells: Antibodies and Beyond
Written by Joanna Wirkus, PhD Introduction B cell basics B cell differentiation Antibodies Monoclonal antibodies in medicine Cytokine production Antigen presentation B cells and gene therapy: animal and human research B lymphocytes were first described in the 1960s by scientists Cooper and Good, who discovered the site of B cell maturation in birds by halting…
For More InformationWhen Politics Blocks Progress: Funding Health Discoveries in Peril
Shifting Political Priorities Threaten the Bedrock of Health Science Investment By: Joanna Wirkus PhD July 2025 ** For scientists under pressure from shifting funding priorities, CGT Global has curated a FREE downloadable funding toolkit with resources to support your long-term funding acquisition strategy. Complete with a grant planning checklist, a curated list of 35+ funding…
For More InformationCGT Sourcing Guide 2025: How to Build a Resilient Supply Chain Amid Tariff Pressures
By CGT Global The latest round of U.S. tariffs didn’t just shake up the headlines—it shook the very foundations of global pharma supply chains. And while most of the buzz has focused on traditional drugmakers, let’s be clear: cell and gene therapy manufacturers aren’t sitting this one out. For companies working with high-value, time-sensitive materials…
For More InformationHow Natural Killer Cells are Revolutionizing Cancer Treatment
By Joanna Wirkus What makes Natural Killer (NK) Cells the Perfect Weapon Against Cancer? Unlike the T cells of the adaptive immune system, innate natural killer (NK) cells protect the body against tumors without prior programming. They recognize and become activated by abnormal cells that lack or express key outer membrane markers characteristic of cancer.…
For More InformationHow to Improve Humanized Mouse Engraftment: CD34+ Cell Sourcing & Viability Tips
By: Joanna Wirkus Simple Steps to Significantly Improve Humanized Mice Engraftment Success Previously in “Overcoming Challenges with Animal Models in Research”, we covered why animal models with human immune systems have significantly improved the translation of preclinical findings into life-saving treatments. Successfully creating these advanced models for testing new therapies relies on high hematopoietic stem…
For More Information